Researchers Identify Serum Biomarkers That “Clearly Separate” COVID-19 From Macrophage Activation Syndrome And Secondary Hemophagocytic Lymphohistiocytosis

May 19, 2021

Healio (5/18, Laday) reports researchers found that “increased interleukin‐1Ra and IL‐8 serum levels, and other biomarker profiles, ‘clearly separate’ COVID-19 from macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis.” The find...